Ledger.Open graph →
SEC Form D · Amendment · filed October 29, 2021

Centry Pharma, Inc

Offering
$15.3M
Sold
$15.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
FORT LEE, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Matthew Kaplan · NEW YORK, NYDirectorKenneth Hoberman · Fort Lee, NJDirectorUri Ben-Or · Fort Lee, NJExecRon Bentsur · Ness Ziona, L3Exec · DirectorShay Shemesh · Fort Lee, NJExecJames Oliviero · Fort Lee, NJDirectorEnrique Poradosu · Fort Lee, NJExecKenneth Hoberman · Fort Lee, NJDirectorUri Ben-Or · Fort Lee, NJExecRon Bentsur · Ness Ziona, L3Exec · DirectorShay Shemesh · Fort Lee, NJExecJames Oliviero · Fort Lee, NJDirectorMatthew Kaplan · New York, NYDirectorEnrique Poradosu · Fort Lee, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗